491
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes

&
Pages 873-891 | Received 01 Apr 2023, Accepted 24 Jul 2023, Published online: 23 Aug 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.